United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 13, 2026 · Filed Jul 14, 2026

On Jul 13, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$536.00 for US$5.09M under a trading plan, leaving 40,513 shares. Filed Jul 14, 2026 (Form 4).

Sold
9,500 shares
Price
US$536.00 average (US$533.70 to US$542.80)
Value
US$5.09M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 13, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jul 13, 2026Common StockSale1,020US$533.7048,993Direct
Jul 13, 2026Common StockSale2,272US$534.6346,721Direct
Jul 13, 2026Common StockSale2,191US$535.4744,530Direct
Jul 13, 2026Common StockSale2,223US$536.5242,307Direct
Jul 13, 2026Common StockSale665US$537.6641,642Direct
Jul 13, 2026Common StockSale409US$538.6041,233Direct
Jul 13, 2026Common StockSale320US$539.6040,913Direct
Jul 13, 2026Common StockSale360US$541.1040,553Direct
Jul 13, 2026Common StockSale40US$542.8040,513Direct

Source

View original at SEC

Related